| Pharmaceutical active ingredients: |
| Coagulation Factor XIII |
| Available forms, composition and doses of Fibrogammin: |
| N / A |
| Fibrogammin medical category: |
| Human:Hemostatics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B02BD07 - Coagulation Factor XIII |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Related documents and information about Fibrogammin: |
| Fibrogammin P prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Innobranduo | Coagulation Factor VIII; Von Willebrand Factor | Francais du Fractionnement et des Biotechnologies Laboratoires |
| Emoclot | Coagulation Factor VIII; Von Willebrand Factor Human | Serono; Biosano Laboratorios; Brazilian Business Consultants; Cristalia Produtos Quimicos Farmaceuticos; Kedrion; Scott-Cassara |
| Emoclot D.I. | Coagulation Factor VIII; Von Willebrand Factor Human | Serono; Biosano Laboratorios; Brazilian Business Consultants; Cristalia Produtos Quimicos Farmaceuticos; Kedrion; Scott-Cassara; Trans Pharmaceuticals |
| Hyate:C | Coagulation Factor VIII-C Porcine | Ipsen Pharma; Medogar; Opopharma; Porton Speywood |
| Hemoleven | Coagulation Factor XI Human | LFB Biomedicaments |
| Fibrogammin P | Coagulation Factor XIII | Sanofi-Aventis; CSL; Rephachem; ZLB Behring |
| Fibrogammine | Coagulation Factor XIII | Sanofi-Aventis |
| Advate | Coagulation Factor, recombinant | Baxter; Zuellig Pharma |
| Kogenate FS | Coagulation Factor, recombinant | Bayer Schering Pharma; Firma Chun Cheong; Zuellig Pharma |
| Kogenate SF | Coagulation Factor, recombinant | Bayer Schering Pharma |